Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion type Assertion NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_head.
- NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion description "[p16INK4A hypermethylation was observed in 58% (29 of 50) of the hepatocellular carcinomas and 16% (6 of 38) of the corresponding chronic hepatitis and cirrhosis tissue samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_provenance.
- NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion evidence source_evidence_literature NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_provenance.
- NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion SIO_000772 15569978 NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_provenance.
- NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion wasDerivedFrom befree-20150227 NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_provenance.
- NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_assertion wasGeneratedBy ECO_0000203 NP304624.RACmPYR-5NoLeZP4JwqV65dC-gxarzgtNq_XyBLYKxK6E130_provenance.